DRTECH Corporation
KOSDAQTotal Valuation
DRTECH Corporation carries a market capitalization of 96.75B, placing it among publicly traded companies globally. Its enterprise value stands at 185.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 96.75B |
| Enterprise Value | 185.97B |
Valuation Ratios
The price-to-sales ratio is 1.02, and the price-to-book ratio stands at -3.44.
| PE Ratio | N/A |
| PS Ratio | 1.02 |
| PB Ratio | -3.44 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | -11.59 |
| P/OCF Ratio | -7.78 |
Enterprise Valuation
The EV/Sales ratio of 1.51 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 0.01 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.51 |
| EV / EBITDA | 0.01 |
| EV / EBIT | 0.01 |
| EV / FCF | N/A |
Financial Position
DRTECH Corporation maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.70 |
| Quick Ratio | 0.34 |
| Debt / Equity | 116.49 |
| Debt / EBITDA | -8.09 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -10.00 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -18.17 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.70 |
Taxes
Over the trailing twelve months, DRTECH Corporation has paid -1.67B in income taxes, reflecting an effective tax rate of 0.00.
| Income Tax | -1.67B |
| Effective Tax Rate | 0.00 |
Stock Price Statistics
DRTECH Corporation's stock has declined approximately -33.27576% over the past 52 weeks. The 50-day moving average sits at 1,459.36, while the 200-day moving average is 1,846.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.27576% |
| 50-Day Moving Average | 1,459.36 |
| 200-Day Moving Average | 1,846.42 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, DRTECH Corporation generated 122.78B in revenue and converted that into -20.52B in net income, yielding earnings per share of -268.56. EBITDA reached -10.97B, while operating income came in at -10.97B.
| Revenue | 122.78B |
| Gross Profit | 47.39B |
| Operating Income | -10.97B |
| Pretax Income | -22.19B |
| Net Income | -20.52B |
| EBITDA | -10.97B |
| EBIT | -10.97B |
| Earnings Per Share (EPS) | -268.56 |
Balance Sheet
DRTECH Corporation holds 28.58B in cash and equivalents against 88.77B in total debt, resulting in a net debt position of 53.83B. Total book value stands at -36.43B, with working capital of 58.78B providing operational flexibility.
| Cash & Cash Equivalents | 28.58B |
| Total Debt | 88.77B |
| Net Debt | 53.83B |
| Equity (Book Value) | -36.43B |
| Book Value Per Share | -476.72 |
| Working Capital | 58.78B |
Cash Flow
DRTECH Corporation produced -16.09B in operating cash flow over the past twelve months. After subtracting -5.28B in capital expenditures, free cash flow totaled -21.37B - equivalent to -279.69 per share.
| Operating Cash Flow | -16.09B |
| Capital Expenditures | -5.28B |
| Free Cash Flow | -21.37B |
| FCF Per Share | -279.69 |
Margins
DRTECH Corporation operates with a gross margin of 38.59, reflecting its pricing power and cost economics. The operating margin of -8.93 and net profit margin of -16.71 provide insight into operational efficiency.
| Gross Margin | 38.59 |
| Operating Margin | -8.93 |
| Pretax Margin | -18.08 |
| Profit Margin | -16.71 |
| EBITDA Margin | -8.93 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -9.19 |
| FCF Yield | -8.63 |
Scores
DRTECH Corporation posts an Altman Z-Score of 1.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.05 |